Abstract
The brainstem is the connecting structure that joins the long tract from the cerebral hemispheres and midline diencephalic nuclei with the cerebellar tracts, forming the spinal cord as the tracts exit through the foramen magnum. Within the brainstem are the nuclei of the cranial nerves, the reticular activating system, and vital function centers (e.g., respiratory). The brainstem includes three anatomic segments: the midbrain, the pons, and the medulla.
Brainstem gliomas account for 20 % of all central nervous system tumors in children. They can be focal, dorsal exophytic tumors or diffuse infiltrating types. The management depends on the location and imaging characteristics. Treatment of diffuse tumors include radiotherapy with or without chemotherapy. Even with the high technological advances in the planning and delivery of radiation the outcomes of this tumors are still poor.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Epstein F, Constantini S (1996) Practical decisions in the treatment of pediatric brain stem tumors. Pediatr Neurosurg 24:24–34
Barkovich AJ, Krischer J, Kun LE et al (1990) Brain stem gliomas: a classification system based on magnetic resonance imaging. Pediatr Neurosurg 16(2):73–83
Farmer JP, Montes JL, Freeman CR et al (2001) Brainstem gliomas. A 10 year institutional review. Pediatr Neurosurg 34(4):206–214
FrFreemaneeman CR, Farmer JP (1998) Pediatric brain stem gliomas: a review. Int J Radiat Oncol Biol Phys 40(2):265–271
Shrieve DC, Wara WM, Edwards MS et al (1992) Hyperfractionated radiation therapy for gliomas of the brainstem in children and in adults. Int J Radiat Oncol Biol Phys 24(4):599–610
Freeman CR, Bourgouin PM, Sanford RA et al (1996) Long term survivors of childhood brain stem gliomas treated with hyperfractionated radiotherapy. Clinical characteristics and treatment related toxicities. Cancer 77(3):555–562
Packer RJ, Boyett JM, Zimmerman RA et al (1993) Hyperfractionated radiation therapy (72 Gy) for children with brain stem gliomas. A Children’s Cancer Group phase I/II trial. Cancer 72(4):1414–1421
Packer RJ, Boyett JM, Zimmerman RA et al (1994) Outcome of children with brain stem gliomas after treatment with 7800 cGy of hyperfractionated radiotherapy. A Children’s Cancer Group phase I/II trial. Cancer 74(6):1827–1834
Albright AL, Guthkelch AN, Packer RJ et al (1986) Prognostic factors in pediatric brain-stem gliomas. J Neurosurg 65(6):751–755
Gilbertson RJ, Hill DA, Hernan R et al (2003) ERBB1 is amplified and overexpressed in high-grade diffusely infiltrative pediatric brain stem glioma. Clin Cancer Res 9(10 Pt 1):3620–3624
Pollack IF, Hoffman HJ, Humphreys RP et al (1993) The long-term outcome after surgical treatment of dorsally exophytic brain-stem gliomas. J Neurosurg 78:859–863
Prados MD, Wara WM, Edwards MS et al (1995) The treatment of brain stem and thalamic gliomas with 78 Gy of hyperfractionated radiation therapy. Int J Radiat Oncol Biol Phys 32(1):85–91
Hoffman HJ (1996) Dorsally exophytic brain stem tumors and midbrain tumors. Pediatr Neurosurg 24:256–262
Khatib ZA, Heideman RL, Kovnar EH et al (1994) Predominance of pilocytic histology in dorsally exophytic brain stem tumors. Pediatr Neurosurg 20:2–10
Albright AL, Packer RJ, Zimmerman R et al (1993) Magnetic resonance scans should replace biopsies for the diagnosis of diffuse brain stem gliomas: a report from the Children’s Cancer Group. Neurosurgery 33:1026–1029
Albright AL (1996) Diffuse brainstem tumors: when is a biopsy necessary? Pediatr Neurosurg 24:252–255
Freeman CR, Krischer JP, Sanford RA et al (1993) Final results of a study of escalating doses of hyperfractionated radiotherapy in brain stem tumors in children: a Pediatric Oncology Group study. Int J Radiat Oncol Biol Phys 27(2):197–206
ICRU Report 29 (1978) Dose specification for reporting external beam therapy with photons and electrons. International Commission on Radiation Units and Measurements, Washington, DC
ICRU Report 50 (1993) Prescribing, recording, and reporting photon beam therapy. International Commission on Radiation Units and Measurements, Bethesda
Antolak JA, Rosen II (1999) Planning target volumes for radiotherapy: how much margin is needed. Int J Radiat Oncol Biol Phys 44:1165–1170
Remeijer P, Rasch C, Lebesque JV et al (1999) A general methodology for three-dimensional analysis of variation in target volume delineation. Med Phys 26:931–940
ICRU Report 62 (1999) Prescribing, recording, and reporting photon beam therapy (Supplement to ICRU Report 50). International Commission on Radiation Units and Measurements, Bethesda
Halperin EC (1985) Pediatric brain stem tumors: patterns of treatment failure and their implications for radiotherapy. Int J Radiat Oncol Biol Phys 11(7):1293–1298
Yoshimura J, Onda K, Tanaka R et al (2003) Clinicopathological study of diffuse type brainstem gliomas: analysis of 40 autopsy cases. Neurol Med Chir (Tokyo) 43(8):375–382
Donahue B, Allen J, Siffert J et al (1998) Patterns of recurrence in brain stem gliomas: evidence for craniospinal dissemination. Int J Radiat Oncol Biol Phys 40(3):677–680
Gajjar A, Sanford RA, Heideman R et al (1997) Low-grade astrocytoma: a decade of experience at St. Jude Children’s Research Hospital. J Clin Oncol 15(8):2792–2799
Dunbar SF, Tarbell NJ, Kooy HM et al (1994) Stereotactic radiotherapy for pediatric and adult brain tumors: preliminary report. Int J Radiat Oncol Biol Phys 30(3):531–539
Freeman CR, Kepner J, Kun LE et al (2000) A detrimental effect of a combined chemotherapy-radiotherapy approach in children with diffuse intrinsic brain stem gliomas. Int J Radiat Oncol Biol Phys 47(3):561–564
Mandell L, Kadota R, Douglass EC et al (1997) It is time to rethink the role of hyperfractionated radiotherapy in the management of children with newly diagnosed brainstem? Results of a Pediatric Oncology Group Phase III trial comparing conventional versus hyperfractionated radiotherapy. Int J Radiat Oncol Biol Phys 39:143
Mandell LR, Kadota R, Freeman C et al (1999) There is no role for hyperfractionated radiotherapy in the management of children with newly diagnosed diffuse intrinsic brainstem tumors: results of a Pediatric Oncology Group phase III trial comparing conventional vs hyperfractionated radiotherapy. Int J Radiat Oncol Biol Phys 43:959
Lewis J, Lucraft H, Gholkar A (1997) UKCCSG study of accelerated radiotherapy for pediatric brain stem gliomas. Int J Radiat Oncol Biol Phys 38(5):925–929
Packer RJ, Prados M, Phillips P et al (1996) Treatment of children with newly diagnosed brain stem gliomas with intravenous recombinant beta-interferon and hyperfractionated radiation therapy: a Children’s Cancer Group phase I/II study. Cancer 77(10):2150–2156
Walter AW, Gajjar A, Ochs JS et al (1998) Carboplatin and etoposide with hyperfractionated radiotherapy in children with newly diagnosed diffuse pontine gliomas: a phase I/II study. Med Pediatr Oncol 30(1):28–33
Jalali R, Raut N, Arora B et al (2010) Prospective evaluation of radiotherapy with concurrent and adjuvant temozolomide in children with newly diagnosed diffuse intrinsic pontine glioma. Int J Radiat Oncol Biol Phys 77(1):113–118
Chiang KL, Chang KP, Lee YY et al (2010) Role of temozolomide in the treatment of newly diagnosed diffuse brainstem glioma in children: experience at a single institution. Childs Nerv Syst 26(8):1035–1041
Sharp JR, Bouffet E, Stempak D et al (2010) A multi-centre Canadian pilot study of metronomic temozolomide combined with radiotherapy for newly diagnosed paediatric brainstem glioma. Eur J Cancer 46(18):3271–3279
Geyer JR, Stewart CF, Kocak M et al (2010) A phase I and biology study of gefitinib and radiation in children with newly diagnosed brain stem gliomas or supratentorial malignant gliomas. Eur J Cancer 46(18):3287–3293, Epub 2010 Aug 12
Packer RJ, Zimmerman RA, Kaplan A et al (1993) Early cystic/necrotic changes after hyperfractionated radiation therapy in children with brain stem gliomas. Cancer 71(8):2666–2674
Liu AK, Brandon J, Foreman NK et al (2009) Conventional MRI at presentation does not predict clinical response to radiation therapy in children with diffuse pontine glioma. Pediatr Radiol 39(12):1317–1320
Griebel M, Friedman HS, Halperin EC et al (1991) Reversible neurotoxicity following hyperfractionated radiation therapy of brain stem glioma. Med Pediatr Oncol 19(3):182–186
Taylor JS, Langston JW, Reddick WE et al (1996) Clinical value of proton magnetic resonance spectroscopy for differentiating recurrent or residual brain tumor from delayed cerebral necrosis. Int J Radiat Oncol Biol Phys 36(5):1251–1261
Hargrave D, Bartels U, Bouffet E (2006) Diffuse brainstem glioma in children: critical review of clinical trials. Lancet Oncol 7(3):241–248
Freeman CR, Perilongo G (1999) Chemotherapy for brain stem gliomas. Childs Nerv Syst 15:545–553
Packer RJ, Littman PA, Sposto RM et al (1987) Results of a pilot study of hyperfractionated radiation therapy for children with brain stem gliomas. Int J Radiat Oncol Biol Phys 13:1647–1651
Freeman CR, Krischer J, Sanford RA et al (1988) Hyperfractionated radiotherapy in brain stem tumors: results of a Pediatric Oncology Group study. Int J Radiat Oncol Biol Phys 15:311–318
Freeman CR, Krischer J, Sanford RA et al (1991) Hyperfractionated radiation therapy in brain stem tumors: results of treatment at the 7020 cGy dose level of Pediatric Oncology Group study #8495. Cancer 68:474–481
Kretschmar CS, Tarbell NJ, Barnes PD et al (1993) Preirradiation chemotherapy and hyperfractionated radiation therapy 66 Gy for children with brain stem tumors: a phase II study of the Pediatric Oncology Group, Protocol 8833. Cancer 72:1404–1413
Allen J, Siffert J, Donahue B et al (1999) A phase I/II study of carboplatin combined with hyperfractionated radiotherapy for brainstem gliomas. Cancer 86:1064–1069
Wolff JE, Westphal S, Molenkamp G et al (2002) Treatment of paediatric pontine glioma with oral trophosphamide and etoposide. Br J Cancer 87:945–949
Packer RJ, Krailo M, Mehta M et al (2005) A phase 1 study of concurrent RMP-7 and carboplatin with radiotherapy for children with newly diagnosed brainstem gliomas. Cancer 104:1968–1974
Broniscer A, Iacono L, Chintagumpala M et al (2005) Role of temozolomide after radiotherapy for newly diagnosed diffuse brainstem glioma in children: results of a multiinstitutional study (SJHG-98). Cancer 103:133–139
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2015 Springer International Publishing Switzerland
About this chapter
Cite this chapter
Caglar, H.B. (2015). Radiotherapy Options of Brainstem Tumors. In: Özek, M., Cinalli, G., Maixner, W., Sainte-Rose, C. (eds) Posterior Fossa Tumors in Children. Springer, Cham. https://doi.org/10.1007/978-3-319-11274-9_36
Download citation
DOI: https://doi.org/10.1007/978-3-319-11274-9_36
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-11273-2
Online ISBN: 978-3-319-11274-9
eBook Packages: MedicineMedicine (R0)